Immunogenicity of tetanus toxoid conjugates of anti-idiotypes that mimic Pseudomonas aeruginosa surface polysaccharides.
AUTOR(ES)
Schreiber, J R
RESUMO
Pseudomonas aeruginosa continues to be a serious pathogen in humans, and there is no commercially available vaccine. We have previously developed monoclonal anti-idiotypic antibodies that mimic two surface polysaccharide epitopes of pseudomonas--the high-molecular-weight polysaccharide of the O side chain of immunotype 1 lipopolysaccharide and mucoid exopolysaccharide. We now show that conjugation of the anti-idiotypes to the carrier tetanus toxoid is not necessary to induce antipolysaccharide antibodies of equal or greater titer than the native polysaccharide antigen in mice.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=186102Documentos Relacionados
- Monoclonal anti-idiotypes induce neutralizing antibodies to enterovirus 70 conformational epitopes.
- Anti-idiotypes against anti-H-2 monoclonal antibodies: structural analysis of the molecules induced by in vivo anti-idiotype treatment.
- Cross-protection by Pseudomonas aeruginosa polysaccharides.
- Crossreactivity and inheritance of idiotypes restricted to human anti-tetanus toxoid antibodies.
- Idiotypes and anti-idiotypes: what are they trying to tell us?
